3P Biopharmaceuticals is a European-based Contract Development and Manufacturing Organization (CDMO) specialized in the development and GMP manufacturing of biopharmaceutical and advanced therapy products from early stages (POC,PC) up to clinical and commercial.
The Company offers an integral service for the development and manufacturing of biopharmaceutical products obtained from either microbial fermentation and mammalian cell culture.
Moreover, manufacturing related services such as analytical method development and validation, stability studies, working and master cell banks (MCB/WCB) manufacturing and characterization, formulation, cell bank storage and advanced therapy services are offered.